| James Klejka, MD | |
|
3975 Embassy Pkwy, Akron, OH 44333-8320 | |
| (330) 668-4094 | |
| Not Available |
| Full Name | James Klejka |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 35 Years |
| Location | 3975 Embassy Pkwy, Akron, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306839709 | NPI | - | NPPES |
| 0918967 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 35.06115 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Crystal Clinic Orthopaedic Center | Akron, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Crystal Clinic Orthopaedic Center, Llc | 6507934015 | 38 |
News Archive
A first-of-its-kind clinical trial involving more than 600 children in Kenya and Tanzania, in which community members were trained to deliver mental health treatment, showed improvement in participants' trauma-related symptoms up to a year after receiving therapy, new research shows.
Researchers led by a team at Rosalind Franklin University of Medicine and Science have devised a new therapeutic approach to treating a rare but deadly neurodegenerative genetic disease in children.
Molecularly targeted therapies can reduce tumors rapidly. However, not all tumors respond to the drugs, and even those that do often develop resistance over time. Looking for a way to combat the problem of resistance, researchers at Fox Chase Cancer Center hypothesized that hitting already weakened cancer cells with a second targeted agent could kill them-but only if it was the right second agent.
A team investigating how genes respond to hormonal changes and inflammation has been awarded a Wellcome Trust grant of 1.24 million for a five-year study
› Verified 5 days ago
| Entity Name | Crystal Clinic Orthopaedic Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669669917 PECOS PAC ID: 6507934015 Enrollment ID: O20150730012144 |
News Archive
A first-of-its-kind clinical trial involving more than 600 children in Kenya and Tanzania, in which community members were trained to deliver mental health treatment, showed improvement in participants' trauma-related symptoms up to a year after receiving therapy, new research shows.
Researchers led by a team at Rosalind Franklin University of Medicine and Science have devised a new therapeutic approach to treating a rare but deadly neurodegenerative genetic disease in children.
Molecularly targeted therapies can reduce tumors rapidly. However, not all tumors respond to the drugs, and even those that do often develop resistance over time. Looking for a way to combat the problem of resistance, researchers at Fox Chase Cancer Center hypothesized that hitting already weakened cancer cells with a second targeted agent could kill them-but only if it was the right second agent.
A team investigating how genes respond to hormonal changes and inflammation has been awarded a Wellcome Trust grant of 1.24 million for a five-year study
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Klejka, MD 3975 Embassy Pkwy, Akron, OH 44333-8320 Ph: (330) 668-4040 | James Klejka, MD 3975 Embassy Pkwy, Akron, OH 44333-8320 Ph: (330) 668-4094 |
News Archive
A first-of-its-kind clinical trial involving more than 600 children in Kenya and Tanzania, in which community members were trained to deliver mental health treatment, showed improvement in participants' trauma-related symptoms up to a year after receiving therapy, new research shows.
Researchers led by a team at Rosalind Franklin University of Medicine and Science have devised a new therapeutic approach to treating a rare but deadly neurodegenerative genetic disease in children.
Molecularly targeted therapies can reduce tumors rapidly. However, not all tumors respond to the drugs, and even those that do often develop resistance over time. Looking for a way to combat the problem of resistance, researchers at Fox Chase Cancer Center hypothesized that hitting already weakened cancer cells with a second targeted agent could kill them-but only if it was the right second agent.
A team investigating how genes respond to hormonal changes and inflammation has been awarded a Wellcome Trust grant of 1.24 million for a five-year study
› Verified 5 days ago
Christopher Najarian, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-8050 | |
Travis Lee Cleland, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3975 Embassy Pkwy Ste 2, Akron, OH 44333 Phone: 330-668-4094 Fax: 330-668-2971 | |
Kathryn A Mosher, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-8050 Fax: 330-543-8054 | |
Adam Butensky Bartlett, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-8050 Fax: 330-543-8054 | |
Steven A. Cremer, D.O. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 999 N Main St, Akron, OH 44310 Phone: 330-929-2694 Fax: 330-929-2782 | |
Benjamin Shekhtman, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 55 Arch St Ste 1b, Akron, OH 44304 Phone: 330-375-3315 Fax: 330-375-7779 |